TVARDI THERAPEUTICS, INC. License and Services Revenue (Deprecated 2018-01-31)
TVARDI THERAPEUTICS, INC. (TVRD) reported License and Services Revenue (Deprecated 2018-01-31) of $0 for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndServicesRevenue · last filed 2014-11-10
- TVARDI THERAPEUTICS, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $0.00.
- TVARDI THERAPEUTICS, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $302.00K, a 96.87% decline year-over-year.
- TVARDI THERAPEUTICS, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $0.00.
- TVARDI THERAPEUTICS, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $9.64M.
| Period end | License and Services Revenue (Deprecated 2018-01-31) 3 month | License and Services Revenue (Deprecated 2018-01-31) 6 month | License and Services Revenue (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 | $302.00K derived: sum of 2 quarters · filed 2014-11-10 | $302.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $302.00K 10-Q · filed 2014-08-07 | $302.00K 10-Q · filed 2014-08-07 | |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-10 | $9.64M derived: sum of 2 quarters · filed 2014-11-10 | $9.64M 10-Q · filed 2014-11-10 |
| 2013-06-30 | $9.64M 10-Q · filed 2014-08-07 | $9.64M 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |